Novel Insights Into Effects of Cortisol and Glucagon on Nocturnal Glucose Production in Type 2 Diabetes.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 07 02 2020
accepted: 30 04 2020
pubmed: 7 5 2020
medline: 4 2 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

The effect of physiological changes in night-time cortisol and glucagon on endogenous glucose production (EGP) and nocturnal glycemia are unknown. To determine the effects of changes in cortisol and glucagon on EGP during the night. Two overnight protocols were conducted. In Protocol 1, endogenous cortisol was blocked with metyrapone and hydrocortisone infused either at constant (constant) or increasing (variable) rates to mimic basal or physiological nocturnal cortisol concentrations. In Protocol 2, endogenous glucagon was blocked with somatostatin and exogenous glucagon was infused at either basal or elevated rates to mimic nocturnal glucagon concentrations observed in nondiabetic (ND) and type 2 diabetes (T2D) individuals. EGP was measured using [3-3H] glucose and gluconeogenesis estimated with 2H2O in all studies. Mayo Clinic Clinical Research Trials Unit, Rochester, MN, US. In Protocol 1, 34 subjects (17 ND and 17 T2D) and in Protocol 2, 39 subjects (21 ND and 18 T2D) were studied. Endogenous glucose production. EGP, gluconeogenesis, and glycogenolysis were higher with variable than with constant cortisol at 7 am in T2D subjects. In contrast, nocturnal EGP did not differ in ND subjects between variable and constant cortisol. While elevated glucagon increased EGP, glycogenolysis, and gluconeogenesis in ND, the data in T2D subjects indicated that EGP and gluconeogenesis but not glycogenolysis were higher during the early part of the night. Nocturnal hyperglucagonemia, but not physiological rise in cortisol, contributes to nocturnal hyperglycemia in T2D due to increased gluconeogenesis.

Identifiants

pubmed: 32374825
pii: 5831336
doi: 10.1210/clinem/dgaa241
pmc: PMC7274493
pii:
doi:

Substances chimiques

Blood Glucose 0
Glucagon 9007-92-5
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK029953
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK085516
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Physiol Endocrinol Metab. 2013 Aug 15;305(4):E465-74
pubmed: 23736541
Diabetes. 2004 Aug;53(8):2042-50
pubmed: 15277384
Diabetes. 2017 Jan;66(1):36-44
pubmed: 27999106
Diabetes. 2005 Jul;54(7):1942-8
pubmed: 15983193
Am J Physiol. 1995 Apr;268(4 Pt 1):E595-603
pubmed: 7733257
Am J Physiol. 1999 Aug;277(2):E283-90
pubmed: 10444424
Diabetologia. 1998 Sep;41(9):987-96
pubmed: 9754815
Diabetes Care. 2019 Apr;42(4):585-593
pubmed: 30765435
Diabetes Obes Metab. 2011 Oct;13 Suppl 1:118-25
pubmed: 21824265
Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E23-30
pubmed: 11120655
Diabetes Obes Metab. 2018 May;20(5):1302-1305
pubmed: 29283470
Diabetes Care. 2009 May;32(5):866-72
pubmed: 19196896
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3801-3809
pubmed: 30020503
Diabetes. 2001 Jun;50(6):1351-62
pubmed: 11375336
J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9
pubmed: 11095432
J Clin Endocrinol Metab. 1982 Jan;54(1):131-8
pubmed: 7033265
Diabetes. 2004 Dec;53(12):3048-56
pubmed: 15561933
Am J Physiol. 1993 Jan;264(1 Pt 1):E119-27
pubmed: 8430780
Diabetes. 2000 Feb;49(2):272-83
pubmed: 10868944
J Clin Invest. 1976 Dec;58(6):1407-18
pubmed: 993351
Diabetes. 1998 Apr;47(4):523-9
pubmed: 9568682
J Clin Invest. 1993 Nov;92(5):2283-90
pubmed: 8227343
Am J Physiol. 1987 Apr;252(4 Pt 1):E565-70
pubmed: 2882686
Metabolism. 1998 Jan;47(1):7-12
pubmed: 9440470
Metabolism. 1996 May;45(5):571-8
pubmed: 8622599
Diabetes Obes Metab. 2018 Feb;20(2):283-291
pubmed: 28755409
Diabetes. 2012 Nov;61(11):2691-700
pubmed: 22751690
Diabetologia. 1995 Mar;38(3):337-43
pubmed: 7758881
Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E55-62
pubmed: 14982753
Diabetes. 2009 Jul;58(7):1539-43
pubmed: 19366865
J Clin Invest. 1996 Jul 15;98(2):378-85
pubmed: 8755648
J Clin Endocrinol Metab. 2013 Mar;98(3):E409-17
pubmed: 23345093

Auteurs

Ananda Basu (A)

Division of Endocrinology, University of Virginia School of Medicine, Charlottesville, VA, US.

Yogesh Yadav (Y)

Division of Endocrinology, University of Virginia School of Medicine, Charlottesville, VA, US.

Rickey E Carter (RE)

Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, US.

Rita Basu (R)

Division of Endocrinology, University of Virginia School of Medicine, Charlottesville, VA, US.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH